Ianiro, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 7.441
EU - Europa 7.102
AS - Asia 6.853
SA - Sud America 1.710
AF - Africa 211
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 13
Totale 23.365
Nazione #
US - Stati Uniti d'America 7.132
SG - Singapore 3.245
DE - Germania 2.004
CN - Cina 1.718
IT - Italia 1.647
BR - Brasile 1.420
SE - Svezia 1.015
FR - Francia 406
VN - Vietnam 388
GB - Regno Unito 362
IE - Irlanda 330
UA - Ucraina 323
IN - India 286
ID - Indonesia 223
FI - Finlandia 219
HK - Hong Kong 203
PL - Polonia 177
CA - Canada 164
RU - Federazione Russa 162
TR - Turchia 126
AR - Argentina 115
KR - Corea 109
NL - Olanda 101
BD - Bangladesh 93
MX - Messico 89
IQ - Iraq 85
JP - Giappone 77
ES - Italia 70
ZA - Sudafrica 54
EC - Ecuador 45
AT - Austria 43
CZ - Repubblica Ceca 38
BE - Belgio 37
CH - Svizzera 37
PK - Pakistan 36
CO - Colombia 35
IR - Iran 30
LT - Lituania 29
AU - Australia 28
UZ - Uzbekistan 28
MA - Marocco 27
JO - Giordania 25
VE - Venezuela 25
CL - Cile 24
TN - Tunisia 24
KE - Kenya 23
EG - Egitto 21
SA - Arabia Saudita 20
PY - Paraguay 18
TW - Taiwan 18
AZ - Azerbaigian 15
DZ - Algeria 15
IL - Israele 15
RO - Romania 14
AE - Emirati Arabi Uniti 13
GR - Grecia 12
PH - Filippine 11
CI - Costa d'Avorio 10
CR - Costa Rica 10
JM - Giamaica 10
PT - Portogallo 10
UY - Uruguay 10
BO - Bolivia 9
KZ - Kazakistan 9
AL - Albania 8
HN - Honduras 8
HU - Ungheria 8
NP - Nepal 8
EU - Europa 7
HR - Croazia 7
OM - Oman 7
PA - Panama 7
PE - Perù 7
RS - Serbia 7
BY - Bielorussia 6
ET - Etiopia 6
LB - Libano 6
LK - Sri Lanka 6
MY - Malesia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
GH - Ghana 5
GT - Guatemala 5
SN - Senegal 5
BH - Bahrain 4
CY - Cipro 4
DO - Repubblica Dominicana 4
GE - Georgia 4
IS - Islanda 4
KG - Kirghizistan 4
KW - Kuwait 4
MM - Myanmar 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
NO - Norvegia 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
Totale 23.308
Città #
Singapore 1.348
Chandler 1.061
Ashburn 742
Beijing 366
Rome 330
Dublin 327
Hefei 272
Los Angeles 232
New York 229
Milan 213
Jakarta 200
San Mateo 197
Hong Kong 188
Jacksonville 185
Ann Arbor 184
Boston 153
Cattolica 150
Wilmington 141
São Paulo 135
Dallas 134
Chicago 130
Ho Chi Minh City 127
Nanjing 127
Warsaw 123
Nürnberg 121
Houston 103
Woodbridge 102
Frankfurt am Main 101
Fairfield 98
Marseille 98
Hanoi 96
Munich 96
Seoul 95
Moscow 91
Princeton 88
Redwood City 81
Boardman 80
Kent 74
Izmir 70
Lawrence 65
London 65
Seattle 64
Dearborn 62
Helsinki 59
Buffalo 58
The Dalles 57
Turku 56
Nuremberg 54
Shanghai 53
Santa Clara 52
Tokyo 49
Las Vegas 43
Hangzhou 42
Belo Horizonte 40
Nanchang 39
Rio de Janeiro 39
Brooklyn 38
Pune 38
Baghdad 37
Denver 37
Atlanta 36
Hyderabad 36
Brussels 35
Cambridge 35
North Bergen 35
Stockholm 35
Toronto 35
Düsseldorf 34
Johannesburg 34
Lappeenranta 33
Leawood 33
Montreal 33
Porto Alegre 33
Orem 32
Tianjin 31
San Francisco 30
Augusta 28
Shenyang 27
Bremen 26
Mexico City 26
Amman 25
Phoenix 25
Washington 25
Amsterdam 24
Chennai 24
Hebei 24
Redmond 24
Zhengzhou 24
Ankara 23
Manchester 23
Norwalk 23
Ottawa 23
Poplar 23
Tashkent 23
Trieste 22
Changsha 21
Dhaka 21
Lancaster 21
Vienna 21
Bologna 20
Totale 10.841
Nome #
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 407
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 323
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 295
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 264
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 254
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 238
Wheat desensitization treatment in patients with gluten sensitivity 234
The role of intestinal microbiota and the immune system 232
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 223
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 207
The role of diet on gut microbiota composition 201
The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial 194
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 193
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 193
White mulberry supplementation as adjuvant treatment of obesity 191
Gut microbiota in autism and mood disorders 182
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 181
Nutritional aspects of Helicobacter pylori infection 178
Fecal microbiota transplantation: Past, present and future perspectives 176
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
13C-octanoic acid breath test to study gastric emptying time 171
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 168
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 168
Can chronic gastritis cause increase of fecal calprotectin concentrations? 160
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 156
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 155
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 154
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 153
Role of gut microbiota in food tolerance and allergies 149
Gut microbiota in autism and mood disorders 148
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 144
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 143
Coeliac disease: an old or a new disease? History of a pathology 142
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features 141
Microscopic colitis 140
Gut microbiome, big data and machine learning to promote precision medicine for cancer 140
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 139
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 138
Gut microbiota and metabolic syndrome 137
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 137
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 135
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 134
Moderately Severe Acute Pancreatitis Associated With Riluzole 133
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 132
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 130
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. 129
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 126
Levothyroxine absorption in health and disease, and new therapeutic perspectives 126
European consensus conference on faecal microbiota transplantation in clinical practice 126
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 125
Histamine-producing bacteria and their role in gastrointestinal disorders 124
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 124
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 124
Diet-Induced Alterations in Gut Microbiota Composition and Function 123
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease 121
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota 120
Autism, gastrointestinal symptoms and modulation of gut microbiota by nutritional interventions 119
Role of N-acetyl-cisteine in the treatment of H. pylori 118
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial 118
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 118
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review 117
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 117
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 115
Detection of rare G3P[19] group A rotavirus in human patient, Italy 114
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 112
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 112
The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota 111
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 111
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 110
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 110
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 110
Pancreatic function assessment 108
Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference 108
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 108
The role of diet in shaping human gut microbiota 106
How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection 105
Gut microbiota and inflammatory bowel disease: an update 104
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota 103
The role of biomarkers in diverticular disease 102
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 101
Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis 100
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 99
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 98
Update on the Role of Rifaximin in Digestive Diseases 97
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 97
From Regular Catharsis with Castor Oil to Recognizing the Importance of the Intestinal Microbiota 97
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 97
Clinical research coordinators: Key components of an efficient clinical trial unit 96
The human gut microbiota and virome: Potential therapeutic implications 96
International consensus statement on microbiome testing in clinical practice 95
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients 95
Proteomics and metabolomics approaches towards a functional insight onto autism spectrum disorders: Phenotype stratification and biomarker discovery 95
FECAL CALPROTECTIN AND NEED OF MULTIPLE MICROBIOTA TRANSPLANTATION INFUSIONS IN CLOSTRIDIUM DIFFICILE INFECTION 94
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease 93
Lynch Syndrome and Thyroid Nodules: A Single Center Experience 92
How the gut parasitome affects human health 92
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 92
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 92
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 90
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 90
Totale 14.107
Categoria #
all - tutte 104.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021704 0 0 0 0 0 97 125 26 120 81 200 55
2021/20221.376 77 78 38 77 93 66 41 221 55 82 277 271
2022/20233.135 413 391 228 444 188 377 156 276 380 83 113 86
2023/20242.046 101 486 94 116 88 277 174 95 56 111 214 234
2024/20254.895 118 153 352 132 326 152 167 243 570 632 1.104 946
2025/20267.258 1.963 477 846 1.520 1.978 474 0 0 0 0 0 0
Totale 23.742